We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

114 hedge funds and large institutions have $1.47B invested in Fusion Pharmaceuticals Inc. Common Shares in 2024 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 3 → 8 (+5)

151% more capital invested

Capital invested by funds: $586M → $1.47B (+$887M)

132% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 28

71% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 14

48% more funds holding

Funds holding: 77 → 114 (+37)

43% less call options, than puts

Call options by funds: $48M | Put options by funds: $84.2M

Holders
114
Holders Change
+37
Holders Change %
+48.05%
% of All Funds
1.64%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
65
Increased
24
Reduced
14
Closed
28
Calls
$48M
Puts
$84.2M
Net Calls
-$36.2M
Net Calls Change
-$36.7M

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$50.1M
2
PA
Perceptive Advisors
New York
+$48.7M
3
PCM
Pentwater Capital Management
Florida
+$45.2M
4
Marshall Wace
Marshall Wace
United Kingdom
+$14.1M
5
Millennium Management
Millennium Management
New York
+$12.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$41.6M
2
O
OrbiMed
New York
-$30M
3
ASP
Adams Street Partners
Illinois
-$28.3M
4
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$11.9M
5
AG
Artal Group
Luxembourg
-$9.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
$684K +$384K +32,097 New
VOYA Investment Management
77
VOYA Investment Management
Georgia
$646K +$362K +30,280 New
YCM
78
Yakira Capital Management
Connecticut
$644K +$361K +30,200 New
GS
79
GTS Securities
New York
$620K +$348K +29,095 New
VF
80
Virtu Financial
New York
$616K +$346K +28,917 New
Citigroup
81
Citigroup
New York
$539K +$287K +23,958 +1,829%
JC
82
JBF Capital
Colorado
$533K +$299K +25,000 New
MTCM
83
Mint Tower Capital Management
Netherlands
$533K +$299K +25,000 New
Allianz Asset Management
84
Allianz Asset Management
Germany
$443K +$249K +20,800 New
NIM
85
NEOS Investment Management
Connecticut
$400K -$146K -12,165 -39%
HF
86
HRT Financial
New York
$381K +$214K +17,911 New
ProShare Advisors
87
ProShare Advisors
Maryland
$376K +$211K +17,623 New
BCM
88
Beryl Capital Management
California
$345K +$194K +16,191 New
TAM
89
Titleist Asset Management
Texas
$342K +$192K +16,050 New
FLC
90
Fifth Lane Capital
Texas
$341K +$191K +16,000 New
Northern Trust
91
Northern Trust
Illinois
$298K +$167K +13,983 New
CUAMC
92
China Universal Asset Management Company
China
$297K +$66.3K +5,544 +66%
ASRS
93
Arizona State Retirement System
Arizona
$255K +$143K +11,939 New
Two Sigma Advisers
94
Two Sigma Advisers
New York
$249K +$2.39K +200 +2%
GI
95
GAMCO Investors
Connecticut
$244K +$137K +11,450 New
CM
96
Crystalline Management
Canada
$239K +$134K +11,207 New
BCM
97
Bluefin Capital Management
New York
$213K +$120K +10,000 New
GCM
98
Greenland Capital Management
New York
$213K +$120K +10,000 New
Teacher Retirement System of Texas
99
Teacher Retirement System of Texas
Texas
$206K +$116K +9,669 New
CL
100
CSS LLC
Illinois
$203K +$114K +9,500 New
2 3
4
5 6

FUSN Hedge Fund Activity: Q1 2024 in Review

114 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q1 2024, worth a combined $1.47B — up 151% from $586M a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new FUSN positions and 28 closed out — a net gain of 37 holders — while 24 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $50.1M. The largest seller was Fidelity Investments, cutting an estimated $41.6M.

  • 114 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q1 2024, up from 77 in Q4 2023.
  • Funds reported $1.47B of Fusion Pharmaceuticals Inc. Common Shares stock for Q1 2024, up 151% quarter-over-quarter.
  • 65 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q1 2024 and 28 closed out, a net change of +37 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q1 2024 was Fidelity International, an estimated $50.1M added.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q1 2024 was Fidelity Investments, an estimated $41.6M sold.

Based on aggregated 13F filings for Q1 2024.